Roundtables

The challenges of Solvency II

Extracting value from Solvency II: a roundtable discussion

The benefits vs the costs, risk appetite, the ORSA, strategic opportunities, diversification benefits. These were just some of the points covered by a group of risk and Solvency II experts during a lively discussion hosted by Deloitte and InsuranceERM

The challenges of Solvency II: a roundtable discussion

Data, the moving regulatory timetable, the IMAP, equivalence with the US and the lack of certainty on key points in the directive are among the challenges faced by re/insurers preparing for Solvency II. Plenty of food for thought and discussion at the roundtable of risk and Solvency II experts hosted by Deloitte and InsuranceERM

Preparing for Solvency II

Solvency II roundtable: how to use the "extra" year

Is the delay in full implementation of Solvency II a boon or a bugbear? What are the implications for the regulators, as well as the regulated? CROs and Solvency II experts debated these and other issues last month in an InsuranceERM roundtable, sponsored by SAS

Solvency II roundtable: embedding processes and live testing are benefits of "extra" year

Priming the board, the use test, the ORSA, "walking" the regulators through insurers' business and processes - these are some of the benefits of the delay in full implementation of Solvency II cited by the CROs and Solvency II experts who debated these issues in an InsuranceERM roundtable, sponsored by SAS